Walleye Capital’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Walleye Capital’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-6,946	Closed	-$188K	–	6074
2024 Q2	$188K	Buy	+6,946	New	+$144K	﹤0.01%	4345
2024 Q1	–	Sell	-121,771	Closed	-$1.49M	–	6037
2023 Q4	$1.49M	Buy	121,771 +107,541	+756%	+$1.01M	﹤0.01%	2014
2023 Q3	$213K	Buy	+14,230	New	+$296K	﹤0.01%	3502
2023 Q2	–	Sell	-7,366	Closed	-$288K	–	4999
2023 Q1	$288K	Buy	+7,366	New	+$360K	﹤0.01%	2168
2021 Q3	–	Sell	-8,750	Closed	-$419	–	1858
2021 Q2	$419	Buy	+8,750	New	+$446K	0.01%	828
2020 Q4	–	Sell	-11,613	Closed	-$781K	–	1143
2020 Q3	$781K	Buy	+11,613	New	+$634K	0.09%	287

Other funds holding SILK

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Walleye Capital's SILK Position: Q3 2024 in Review

Walleye Capital sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 6,946 shares — an estimated $188K sold.

Walleye Capital first reported a position in SILK in Q3 2020 and held it in 6 quarters. The position peaked at $1.49M in Q4 2023. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

Walleye Capital reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Walleye Capital sold 6,946 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $188K.
Walleye Capital first reported a position in Silk Road Medical, Inc. Common Stock in Q3 2020 and held it in 6 quarters.
Walleye Capital's Silk Road Medical, Inc. Common Stock position peaked at $1.49M in Q4 2023.
1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Walleye Capital's 13F filing for Q3 2024, filed 14 Nov 2024.